Lichun Ma

National Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Hien Dang

Assistant Professor

Thomas Jefferson University

UNITED STATES

View details

Aiwu He

Associate Professor

Georgetown University

UNITED STATES

View details

Mark Yarchoan

Johns Hopkins University

UNITED STATES

View details

Tim Greten

National Institutes of Health

UNITED STATES

View details

Stephen Hewitt

Editor-in-Chief

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lichun Ma

Research Interests

Explore related searches

Contact this professor

Articles (14)

Biomarkers for immunotherapy of hepatocellular carcinoma

Immunology and immunotherapy of cholangiocarcinoma

Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy

Spatial proximity of tumor-immune interactions predicts patient outcome in hepatocellular carcinoma

Immunosuppressive CD29+ Treg accumulation in the liver in mice on checkpoint inhibitor therapy

Spatial proximity of Tumor-Immune interactions predicts patient outcome in hepatocellular carcinoma

Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer

Dissecting liver tumor heterogeneity to improve health equity

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

A compendium of co-regulated mitoribosomal proteins in pan-cancer uncovers collateral defective events in tumor malignancy

Hypoxia is a key regulator in liver cancer progression

Intratumoral γδ T-cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma.

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.

Collaborators (5)

Hien Dang

Aiwu He

Mark Yarchoan

Tim Greten

Stephen Hewitt

Make your next move.